An analyst waxed bullish on the company's leading pipeline program.

In case you’ve missed it, weight-loss meds like Ozempic, Wegovy, and Mounjaro are the talk of Hollywood right now. These ...

Grammy winner Lizzo shared a vulnerable video detailing a difficult day in her weight loss journey and reminded her followers ...

Ozempic-curious people are taking a novel approach to using the blockbuster weight loss drug — and some doctors are even ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

Roche focuses on obesity drug development, fast-tracking its CT-388 candidate, and targeting $3.6 billion in annual sales.

Rivus already announced in August that the trial hit its key endpoint, but today fleshed out that win with some figures.

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...